Covalon Technologies Stock Today
| CVALF Stock | USD 2.68 0.03 1.13% |
Performance7 of 100
| Odds Of DistressLess than 19
|
Covalon Technologies is trading at 2.68 as of the 26th of November 2024. This is a 1.13 percent increase since the beginning of the trading day. The stock's lowest day price was 2.59. Covalon Technologies has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Covalon Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of July 2023 and ending today, the 26th of November 2024. Click here to learn more.
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. The company has 25.07 M outstanding shares. More on Covalon Technologies
Moving against Covalon OTC Stock
| 0.84 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.83 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.82 | TCHH | Trustcash Holdings | PairCorr |
| 0.71 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.67 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.65 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Covalon OTC Stock Highlights
| CEO and President and Director | Brian Pedlar |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Covalon Technologies [CVALF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 41.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Covalon Technologies's market, we take the total number of its shares issued and multiply it by Covalon Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Covalon Technologies classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 25.07 M outstanding shares.
Covalon Technologies has accumulated about 14.04 M in cash with (7.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55.
Check Covalon Technologies Probability Of Bankruptcy
Ownership AllocationCovalon Technologies holds a total of 25.07 Million outstanding shares. Covalon Technologies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Covalon Ownership Details
Covalon Technologies Risk Profiles
| Mean Deviation | 1.87 | |||
| Semi Deviation | 2.01 | |||
| Standard Deviation | 2.63 | |||
| Variance | 6.92 |
Covalon Stock Against Markets
Picking the right benchmark for Covalon Technologies otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Covalon Technologies otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Covalon Technologies is critical whether you are bullish or bearish towards Covalon Technologies at a given time. Please also check how Covalon Technologies' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Covalon Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Covalon Technologies Corporate Management
Elected by the shareholders, the Covalon Technologies' board of directors comprises two types of representatives: Covalon Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Covalon. The board's role is to monitor Covalon Technologies' management team and ensure that shareholders' interests are well served. Covalon Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Covalon Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Simon Smith | Chief Ltd | Profile | |
| Ron Hebert | VP Marketing | Profile | |
| Greg Leszczynski | VP HR | Profile | |
| Hamed Abbasian | VP Devel | Profile | |
| Gerry Arambula | Pres Ltd | Profile |
Other Information on Investing in Covalon OTC Stock
Covalon Technologies financial ratios help investors to determine whether Covalon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Covalon with respect to the benefits of owning Covalon Technologies security.